Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30

$6.39−0.13 (-1.99%)

Close on Nov 13, 2026Market cap $856.72MP/E –Yield –

Immatics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Immatics's EV/EBITDA was 15.7× on Feb 29, 2024.

Period	Period end	Value	Change (pts)
2024	Feb 29, 2024	15.7×	+1.4
2023	Dec 29, 2023	14.2×	–

See a number that looks wrong?